Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of delgocitinib cream in adolescents with moderate to severe chronic hand eczema
2021-006340-27Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic hand dermatitis (CHE) comparing Delgocitinib cream with Cream vehicle (2 arms). Started Mar 2022; status: completed.
02
Drugs
delgocitinib
03
Conditions
chronic hand dermatitis (CHE)
Beyond the preview
Go deeper on 2021-006340-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006340-27.